Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 5/20 | 0.46 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.46 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | LOX | P28300 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 4/20 | 0.39 |
| ▸ | ACACA | Q13085 | 3/20 | 0.39 |
| ▸ | CKS1B | P61024 | 2/20 | 0.38 |
| ▸ | SKP1 | P63208 | 2/20 | 0.38 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.37 |
| ▸ | GLS | O94925 | 1/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 2/20 | 0.35 |
| ▸ | CTSK | P43235 | 2/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29971303 | 0.94 | LOXL2 (0.45) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274636 | 0.91 | LOXL2 (0.45) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274612 | 0.90 | LOXL2 (0.46) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL20983568 | 0.89 | LOXL2 (0.45) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274318 | 0.89 | LOXL2 (0.46) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274312 | 0.89 | LOXL3 (0.44) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274309 | 0.88 | LOXL2 (0.45) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274724 | 0.88 | LOXL2 (0.45) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274732 | 0.88 | LOXL2 (0.45) | LOXL2LOXL3PDPK1HDAC1ACACB | |
| SCHEMBL19274640 | 0.87 | LOXL2 (0.40) | LOXL2LOXL3PDPK1HDAC1ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3416956-A1 | METHYLAMINE DERIVATIVES AS LYSYSL OXIDASE INHIBITORS FOR THE TREATMENT OF CANCER | The Institute of Cancer Research : The Royal Cancer Hospital (GB) | 2018-12-26 | — | — | EP | disclosed |
| WO-2017141049-A1 | METHYLAMINE DERIVATIVES AS LYSYSL OXIDASE INHIBITORS FOR THE TREATMENT OF CANCER | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2017-08-24 | — | — | WO | disclosed |
| WO-2017141049-A1 | METHYLAMINE DERIVATIVES AS LYSYSL OXIDASE INHIBITORS FOR THE TREATMENT OF CANCER | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2017-08-24 | — | — | WO | disclosed |